CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims ...

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

Dr. Cook answers the question: 'Pros of Giving Insulin By Pen/Syringe?' — -- Question:What are the pros and cons of giving insulin by syringe and by pen? Answer:Well the pen-versus-syringe ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Nine percent of Americans, about 30 million people, have ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected ...